169 related articles for article (PubMed ID: 33106058)
1. Discovery of a potential biomarker for immunotherapy of melanoma: PLAC1 as an emerging target.
Mahmoudi AR; Ghods R; Rakhshan A; Madjd Z; Bolouri MR; Mahmoudian J; Rahdan S; Shokri MR; Dorafshan S; Shekarabi M; Zarnani AH
Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):604-613. PubMed ID: 33106058
[TBL] [Abstract][Full Text] [Related]
2. Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy.
Nejadmoghaddam MR; Zarnani AH; Ghahremanzadeh R; Ghods R; Mahmoudian J; Yousefi M; Nazari M; Ghahremani MH; Abolhasani M; Anissian A; Mahmoudi M; Dinarvand R
Sci Rep; 2017 Oct; 7(1):13373. PubMed ID: 29042604
[TBL] [Abstract][Full Text] [Related]
3. PLAC1: biology and potential application in cancer immunotherapy.
Mahmoudian J; Ghods R; Nazari M; Jeddi-Tehrani M; Ghahremani MH; Ghaffari-Tabrizi-Wizsy N; Ostad SN; Zarnani AH
Cancer Immunol Immunother; 2019 Jul; 68(7):1039-1058. PubMed ID: 31165204
[TBL] [Abstract][Full Text] [Related]
4. Immunization with placenta-specific 1 (plac1) induces potent anti-tumor responses and prolongs survival in a mouse model of melanoma.
Rahdan S; Razavi SA; Shojaeian S; Shokri F; Amiri MM; Zarnani AH
Adv Med Sci; 2022 Sep; 67(2):338-345. PubMed ID: 36084365
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma.
Yin Y; Zhu X; Huang S; Zheng J; Zhang M; Kong W; Chen Q; Zhang Y; Chen X; Lin K; Ouyang X
Tumour Biol; 2017 Jun; 39(6):1010428317699131. PubMed ID: 28618924
[TBL] [Abstract][Full Text] [Related]
6. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism.
Canè S; Van Snick J; Uyttenhove C; Pilotte L; Van den Eynde BJ
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637600
[TBL] [Abstract][Full Text] [Related]
7. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of plac1 in murine cancer cell lines.
Mahmoudian J; Ghods R; Nazari M; Jeddi-Tehrani M; Ghahremani MH; Ostad SN; Zarnani AH
Exp Oncol; 2019 Mar; 41(1):7-13. PubMed ID: 30932401
[TBL] [Abstract][Full Text] [Related]
9. Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.
Tchabo NE; Mhawech-Fauceglia P; Caballero OL; Villella J; Beck AF; Miliotto AJ; Liao J; Andrews C; Lele S; Old LJ; Odunsi K
Cancer Immun; 2009 Aug; 9():6. PubMed ID: 19705800
[TBL] [Abstract][Full Text] [Related]
10. PLAC1 immunization does not induce infertility in mice.
Liso A; Massenzio F; Stracci F
Immunotherapy; 2017 May; 9(6):481-486. PubMed ID: 28351180
[TBL] [Abstract][Full Text] [Related]
11. Closed system RT-qPCR as a potential companion diagnostic test for immunotherapy outcome in metastatic melanoma.
Gupta S; McCann L; Chan YGY; Lai EW; Wei W; Wong PF; Smithy JW; Weidler J; Rhees B; Bates M; Kluger HM; Rimm DL
J Immunother Cancer; 2019 Sep; 7(1):254. PubMed ID: 31533832
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of HGF are correlated with response to anti-PD-1 antibody therapy in patients with metastatic melanoma.
Kubo Y; Fukushima S; Inamori Y; Tsuruta M; Egashira S; Yamada-Kanazawa S; Nakahara S; Tokuzumi A; Miyashita A; Aoi J; Kajihara I; Tomita Y; Wakamatsu K; Jinnin M; Ihn H
J Dermatol Sci; 2019 Jan; 93(1):33-40. PubMed ID: 30318169
[TBL] [Abstract][Full Text] [Related]
13. Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97.
Smith LM; Nesterova A; Alley SC; Torgov MY; Carter PJ
Mol Cancer Ther; 2006 Jun; 5(6):1474-82. PubMed ID: 16818506
[TBL] [Abstract][Full Text] [Related]
14. Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma.
Hayashi R; Nagato T; Kumai T; Ohara K; Ohara M; Ohkuri T; Hirata-Nozaki Y; Harabuchi S; Kosaka A; Nagata M; Yajima Y; Yasuda S; Oikawa K; Kono M; Kishibe K; Takahara M; Katada A; Hayashi T; Celis E; Harabuchi Y; Kobayashi H
Oncoimmunology; 2020 Dec; 10(1):1856545. PubMed ID: 33457076
[TBL] [Abstract][Full Text] [Related]
15. Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.
Xu DH; Zhu Z; Xiao H; Wakefield MR; Bai Q; Nicholl MB; Ding VA; Fang Y
Cancer Lett; 2017 May; 394():43-51. PubMed ID: 28254411
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical characterization of novel murine monoclonal antibodies against human placenta-specific 1.
Ghods R; Ghahremani MH; Darzi M; Mahmoudi AR; Yeganeh O; Bayat AA; Pasalar P; Jeddi-Tehrani M; Zarnani AH
Biotechnol Appl Biochem; 2014; 61(3):363-9. PubMed ID: 24237073
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma.
Zhao CY; Hwang SJE; Anforth R; Carlos G; Chou S; Carlino M; Fernández-Peñas P
J Immunother; 2018 Sep; 41(7):343-349. PubMed ID: 29939876
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression as a potential predictive biomarker.
Fusi A; Festino L; Botti G; Masucci G; Melero I; Lorigan P; Ascierto PA
Lancet Oncol; 2015 Oct; 16(13):1285-7. PubMed ID: 26433815
[No Abstract] [Full Text] [Related]
19. Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients.
Dong XY; Peng JR; Ye YJ; Chen HS; Zhang LJ; Pang XW; Li Y; Zhang Y; Wang S; Fant ME; Yin YH; Chen WF
Int J Cancer; 2008 May; 122(9):2038-43. PubMed ID: 18183594
[TBL] [Abstract][Full Text] [Related]
20. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Ren Y; Lv Y; Li T; Jiang Q
Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
